
Joshua Joo
Examiner (ID: 11954, Phone: (571)272-3966 , Office: P/2445 )
| Most Active Art Unit | 2445 |
| Art Unit(s) | 2154, 2454, 2445 |
| Total Applications | 1186 |
| Issued Applications | 850 |
| Pending Applications | 94 |
| Abandoned Applications | 264 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6939813
[patent_doc_number] => 20050113376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury'
[patent_app_type] => utility
[patent_app_number] => 10/854648
[patent_app_country] => US
[patent_app_date] => 2004-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25077
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10854648
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/854648 | Compositions of a cyclooxygenase-2 selective inhibitor, a xanthine compound and an alcohol for the treatment of ischemic mediated central nervous system disorders or injury | May 25, 2004 | Abandoned |
Array
(
[id] => 843732
[patent_doc_number] => 07388030
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-17
[patent_title] => 'Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite'
[patent_app_type] => utility
[patent_app_number] => 10/851338
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8029
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/388/07388030.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851338
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851338 | Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite | May 23, 2004 | Issued |
Array
(
[id] => 7089780
[patent_doc_number] => 20050009893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Treatment of high blood pressure during the acute phase of a stroke'
[patent_app_type] => utility
[patent_app_number] => 10/851660
[patent_app_country] => US
[patent_app_date] => 2004-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1394
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009893.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851660 | Treatment of high blood pressure during the acute phase of a stroke | May 23, 2004 | Abandoned |
Array
(
[id] => 7378407
[patent_doc_number] => 20040220188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Alkylidene pyrazolidinedione derivatives'
[patent_app_type] => new
[patent_app_number] => 10/481240
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26204
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10481240
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/481240 | Alkylidene pyrazolidinedione derivatives | May 20, 2004 | Abandoned |
Array
(
[id] => 7378368
[patent_doc_number] => 20040220184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)'
[patent_app_type] => new
[patent_app_number] => 10/851826
[patent_app_country] => US
[patent_app_date] => 2004-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11121
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220184.pdf
[firstpage_image] =>[orig_patent_app_number] => 10851826
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/851826 | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) | May 20, 2004 | Abandoned |
Array
(
[id] => 7297517
[patent_doc_number] => 20040214845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Barbiturates as integrin antagonists and their use for treating inflammatory diseases'
[patent_app_type] => new
[patent_app_number] => 10/848718
[patent_app_country] => US
[patent_app_date] => 2004-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6057
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10848718
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/848718 | Barbiturates as integrin antagonists and their use for treating inflammatory diseases | May 18, 2004 | Abandoned |
Array
(
[id] => 6939870
[patent_doc_number] => 20050113433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system'
[patent_app_type] => utility
[patent_app_number] => 10/845009
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15041
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113433.pdf
[firstpage_image] =>[orig_patent_app_number] => 10845009
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/845009 | Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous system | May 12, 2004 | Abandoned |
Array
(
[id] => 435962
[patent_doc_number] => 07262219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy'
[patent_app_type] => utility
[patent_app_number] => 10/841709
[patent_app_country] => US
[patent_app_date] => 2004-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28657
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/262/07262219.pdf
[firstpage_image] =>[orig_patent_app_number] => 10841709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/841709 | Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy | May 6, 2004 | Issued |
Array
(
[id] => 7434448
[patent_doc_number] => 20040209952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Composition containing chalcone'
[patent_app_type] => new
[patent_app_number] => 10/838853
[patent_app_country] => US
[patent_app_date] => 2004-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6137
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209952.pdf
[firstpage_image] =>[orig_patent_app_number] => 10838853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/838853 | Composition containing chalcone | May 2, 2004 | Issued |
Array
(
[id] => 577975
[patent_doc_number] => 07456179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-25
[patent_title] => 'Methods of treating ischemic related conditions'
[patent_app_type] => utility
[patent_app_number] => 10/835668
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11898
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/456/07456179.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835668
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835668 | Methods of treating ischemic related conditions | Apr 29, 2004 | Issued |
Array
(
[id] => 7352068
[patent_doc_number] => 20040248928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Pharmaceutical composition comprising an adenosine A1/A2 agonist and a sodium hydrogen exchanger inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/835964
[patent_app_country] => US
[patent_app_date] => 2004-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8012
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248928.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835964
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835964 | Pharmaceutical composition comprising an adenosine A1/A2 agonist and a sodium hydrogen exchanger inhibitor | Apr 29, 2004 | Abandoned |
Array
(
[id] => 7330095
[patent_doc_number] => 20040254208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Compositions for affecting weight loss'
[patent_app_type] => new
[patent_app_number] => 10/828795
[patent_app_country] => US
[patent_app_date] => 2004-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14960
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254208.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828795 | Compositions for affecting weight loss | Apr 20, 2004 | Issued |
Array
(
[id] => 7466830
[patent_doc_number] => 20040198771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-07
[patent_title] => 'Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation'
[patent_app_type] => new
[patent_app_number] => 10/823862
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16614
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20040198771.pdf
[firstpage_image] =>[orig_patent_app_number] => 10823862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/823862 | Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smooth muscle cell proliferation | Apr 13, 2004 | Issued |
Array
(
[id] => 4675584
[patent_doc_number] => 20080213213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione'
[patent_app_type] => utility
[patent_app_number] => 11/547927
[patent_app_country] => US
[patent_app_date] => 2004-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24271
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213213.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547927 | Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione | Apr 13, 2004 | Abandoned |
Array
(
[id] => 7127912
[patent_doc_number] => 20050059656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Compositions and methods for protecting against mitochondria component-mediated pathology'
[patent_app_type] => utility
[patent_app_number] => 10/820184
[patent_app_country] => US
[patent_app_date] => 2004-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 280
[patent_figures_cnt] => 280
[patent_no_of_words] => 9961
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059656.pdf
[firstpage_image] =>[orig_patent_app_number] => 10820184
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/820184 | Compositions and methods for protecting against mitochondria component-mediated pathology | Apr 6, 2004 | Abandoned |
Array
(
[id] => 7672936
[patent_doc_number] => 20040180843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Treatment of helicobacter with isothocyanates'
[patent_app_type] => new
[patent_app_number] => 10/813015
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7780
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180843.pdf
[firstpage_image] =>[orig_patent_app_number] => 10813015
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/813015 | Treatment of Helicobacter with isothiocyanates | Mar 30, 2004 | Issued |
Array
(
[id] => 7018843
[patent_doc_number] => 20050220862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Compositions with reduced hepatotoxicity'
[patent_app_type] => utility
[patent_app_number] => 10/813760
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1708
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220862.pdf
[firstpage_image] =>[orig_patent_app_number] => 10813760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/813760 | Compositions with reduced hepatotoxicity | Mar 30, 2004 | Abandoned |
Array
(
[id] => 7347622
[patent_doc_number] => 20040192773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Preventive or remedy for hypertension'
[patent_app_type] => new
[patent_app_number] => 10/810611
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4680
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192773.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810611
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810611 | Preventive or remedy for hypertension | Mar 28, 2004 | Issued |
Array
(
[id] => 7672816
[patent_doc_number] => 20040180963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease'
[patent_app_type] => new
[patent_app_number] => 10/810682
[patent_app_country] => US
[patent_app_date] => 2004-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4167
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180963.pdf
[firstpage_image] =>[orig_patent_app_number] => 10810682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/810682 | Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease | Mar 28, 2004 | Abandoned |
Array
(
[id] => 7351399
[patent_doc_number] => 20040248825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Use of neuraminidase inhibitors to prevent flu associated bacterial infections'
[patent_app_type] => new
[patent_app_number] => 10/809127
[patent_app_country] => US
[patent_app_date] => 2004-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10450
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10809127
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/809127 | Use of neuraminidase inhibitors to prevent flu associated bacterial infections | Mar 24, 2004 | Abandoned |